18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial
Research output: Contribution to journal › Journal article › Research › peer-review
The most widely studied positron emission tomography ligand for in vivo beta-amyloid imaging is (11)C-Pittsburgh compound B ((11)C-PIB). Its availability, however, is limited by the need for an on-site cyclotron. Validation of the (18)F-labeled PIB derivative (18)F-flutemetamol could significantly enhance access to this novel technology.
| Original language | English |
|---|---|
| Journal | Annals of Neurology |
| Volume | 68 |
| Issue number | 3 |
| Pages (from-to) | 319-29 |
| Number of pages | 11 |
| ISSN | 0364-5134 |
| DOIs | |
| Publication status | Published - 2010 |
ID: 34091263